lencana Anda Rentang 52M $3–$8 2% of range Peringkat Analis BUY 14 analysts Target Harga $26 +852% upside P/E -2.0 ROE -33.7% Margin Laba Bersih ·

TARA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03
Harga $2.70
Kapitalisasi Pasar (MRQ) $160M
P/E -2.0
EPS $-1.34
ROE -33.7%
Rentang 52M $3–$8

TARA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04
rentang
batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Pemecahan saham 1
Tanggal ex-dividen Pemecahan Tipe
10 Jan. 2020 1-for-40 Terbalik

Tentang Protara Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.

Company History

Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.

The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing.

On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million. The company went public in 2014.

In September 2019, Proteon Therapeutics merged with ArTara Therapeutics.

PRT-201

Proteon is developing PRT-201 (vonapanitase), a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). PRT-201 is a recombinant human elastase manufactured for Proteon by Lonza.

In September 2008, the company announced that the Food and Drug Administration had granted fast track status to PRT-201.

In December 2016, they announced that the phase III trial of PRT-201 hadn't reached its primary endpoint, causing Proteon's stock price to drop more than 75%.

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorHealthcare industriBiotechnology karyawan46 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06
EPS$-1.34
2021-12-31 → 2025-12-31
Arus Kas Bebas$-56M
2016-12-31 → 2025-12-31
Margin bersih·
2020-12-31 → 2020-12-31
Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik Tren 5 Tahun TARA rata-rata 5T Median Rekan Kesimpulan
P/E -2.0rata-rata 5T ≈-1.8 ≈-1.8 · ·
P/B (MRQ) 1.0rata-rata 5T ≈0.7 ≈0.7 2.1 Kurang nilai
Price / FCF (Harga / FCF) -2.6rata-rata 5T ≈-2.8 ≈-2.8 · ·
Price / Cash Flow (Harga / Arus Kas) -2.6rata-rata 5T ≈-2.8 ≈-2.8 · ·
Price / Tangible Book (Harga / Nilai Buku Berwujud) 0.7rata-rata 5T ≈0.7 ≈0.7 · ·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14
Kejutan Rata-rata 12.0%
Laporan Berikutnya Nov 09, 2026
PeriodeLaporanEPS AktualEPS EstimasiKejutan
30 Juni 2026 Agu 10, 2026 $-0.36 $-0.33 -8.4%
31 Maret 2026 $-0.31 $-0.38 18.8%
31 Des. 2025 $-0.37 $-0.33 -11.6%
30 Sep. 2025 $-0.31 $-0.39 20.9%
30 Juni 2025 $-0.35 $-0.41 15.3%
31 Maret 2025 $-0.29 $-0.46 37.1%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15
Laporan Laba Rugi 16
Metrik Tren 202520242023202220212020201920182017201620152014
Revenue ···········$3M
R&D Expense $43M$32M$25M$17M$21M$12M$4M$12M$22M$19M$12M$6M
SG&A Expense $22M$17M$19M$21M$26M$22M$4M$10M$9M$10M$8M$4M
Operating Expenses $65M$49M$44M$67M$47M$34M$8M$21M$30M$29M$21M$11M
Operating Income $-65M$-49M$-44M$-67M$-47M$-34M$-8M$-21M$-30M$-29M$-21M$-8M
Interest Expense ····$0$34.0K·····$857.0K
Interest Income $6M$4M$3M$1M$237.0K$500.0K······
Other Non-op $7M$5M$3M$1M$237.0K$466.0K·$207.0K$139.0K$-14.0K$-651.0K$5M
Pretax Income $57M$45M····$-15M$-21M$-30M$-29M$-21M$-3M
Income Tax ···········$-110.0K
Net Income $-57M$-45M$-40M$-66M$-47M$-34M$-8M$-21M$-30M$-29M$-21M$-3M
EPS (Basic) $-1.34$-2.17$-3.57$-5.86$-4.21·······
EPS (Diluted) $-1.34$-2.17$-3.57$-5.86$-4.21·······
Shares (Basic) 42,836,12920,592,84711,331,33811,259,615········
Shares (Diluted) 42,836,12920,592,84711,331,33811,259,61511,232,576·······
EBITDA $-65M$-49M$-44M$-67M$-47M$-34M$-15M··$-29M$-21M$-8M
Neraca 23
Metrik Tren 202520242023202220212020201920182017201620152014
Cash & Equivalents $50M$163M$40M$24M$36M$169M$564.0K$19M$21M$36M$40M$69M
Short-term Investments $106M$7M$26M$60M$56M··$2M$21M$5M$25M$15M
Prepaid Expense $4M$2M$3M$2M$2M$787.0K$78.0K$1M$1M$1M$1M$1M
Other Current Assets $65.0K$2.0K$37.0K$127.0K$34.0K$52.0K······
Current Assets $160M$172M$69M$86M$93M$169M$764.0K$23M$43M$43M$67M$85M
PP&E (Net) $759.0K$1M$1M$2M$2M$1M$459.0K$263.0K$259.0K$372.0K$224.0K$83.0K
PP&E (Gross) $2M$2M$2M$2M$2M$1M$475.0K$1M$971.0K$937.0K$665.0K$467.0K
Accum. Depreciation $1M$1M$824.0K$483.0K$236.0K$119.0K$16.0K$827.0K$712.0K$565.0K$441.0K$384.0K
Goodwill ····$30M$30M······
Other Non-current Assets $20.0K$27.0K$11.0K$16.0K$865.0K$1M··$218.0K$393.0K$706.0K$114.0K
Total Assets $209M$181M$79M$113M$173M$203M$1M$24M$44M$44M$68M$85M
Accounts Payable $3M$4M$2M$2M$954.0K$914.0K$716.0K$441.0K$291.0K$556.0K$1M$917.0K
Accrued Liabilities $6M$5M$3M$3M$2M$2M$3M$3M$9M$5M$3M$1M
Current Liabilities $11M$11M$6M$6M$4M$3M$3M$3M$9M$5M$4M$2M
Capital Leases $2M$3M$4M$5M$6M$999.0K······
Total Liabilities $13M$14M$11M$11M$11M$4M$3M$3M$9M$5M$4M$2M
Common Stock $54.0K$35.0K$11.0K$11.0K$11.0K$11.0K$3.0K·$18.0K$17.0K$16.0K$16.0K
Paid-in Capital $499M$412M$269M$263M$256M$246M$11M$209M$203M$198M$195M$192M
Retained Earnings $-302M$-245M$-200M$-160M$-94M$-47M$-13M$-210M$-190M$-160M$-131M$-110M
AOCI $90.0K$2.0K$-31.0K$-688.0K$-211.0K·$3.0K$5.0K$-14.0K·$-11.0K$-6.0K
Stockholders' Equity $196M$167M$68M$102M$162M$199M$-2M$5M$35M$38M$63M$82M
Liabilities + Equity $209M$181M$79M$113M$173M$203M$1M$24M$44M$44M$68M$85M
Shares Outstanding 53,587,26035,044,77211,364,90311,267,38911,235,73111,211,8402,627,533481,09117,674,72916,603,55916,501,50016,448,455
Arus Kas 14
Metrik Tren 202520242023202220212020201920182017201620152014
D&A ·········$123.0K$57.0K$30.0K
Stock-based Comp $4M$4M$6M$7M$10M$10M$424.0K$3M$3M$3M$2M$459.0K
Deferred Tax $-11M$-20M$-14M$-9M$-5M$-9M······
Restructuring ······$3M·····
Other Non-cash ·········$1M$2M$-7M
Operating Cash Flow $-56M$-36M$-38M$-26M$-35M$-23M$-5M$-23M$-22M$-24M$-18M$-10M
CapEx $94.0K$63.0K$45.0K$120.0K$596.0K$884.0K$475.0K$119.0K$35.0K$271.0K$198.0K$51.0K
Investing Cash Flow $-139M$19M$53M$15M$-98M$3M$-475.0K$18M$-16M$20M$-11M·
Stock Issued ·····$74M·····$62M
Stock Repurchased ··$91.0K$90.0K$228.0K·······
Net Stock Activity ··$-91.0K$-90.0K$-228.0K$66M·····$62M
Financing Cash Flow $83M$140M$-91.0K$-90.0K$-228.0K$189M$500.0K$3M$23M$208.0K$163.0K·
Net Change in Cash ······$-13M$-2M$-15M$-4M$-29M$66M
Free Cash Flow $-56M$-36M$-38M$-27M$-35M$-24M$-16M··$-24M$-18M$-10M
Profitabilitas 5
Metrik Tren 202520242023202220212020201920182017201620152014
Operating Margin ·····-7391.4%·····-257.1%
Net Margin ·····-7291.4%·····-113.4%
EBITDA Margin ·····-7391.4%·····-256.1%
ROA -29.4%-34.2%-42.0%-46.1%-25.1%-33.2%-98.3%··-51.4%-28.1%-7.4%
ROE -33.7%-35.8%-55.6%-54.7%-28.4%-17.2%-449.1%··-56.0%-29.3%37.0%
Likuiditas & Solvabilitas 3
Metrik Tren 202520242023202220212020201920182017201620152014
Current Ratio 14.615.711.215.021.758.112.0··8.416.136.2
Quick Ratio 14.215.510.714.721.257.810.6··8.115.835.8
Interest Coverage ·····-1013.1·····-8.8
Efisiensi 1
Metrik Tren 202520242023202220212020201920182017201620152014
Asset Turnover ·····0.0·····0.1
Per Saham 4
Metrik Tren 202520242023202220212020201920182017201620152014
Book Value / Share $3.67$4.77$6.01$9.06$14.41$17.77$11.46··$2.32$3.84$5.01
Cash Flow / Share $-1.32$-1.74$-3.31$-2.35········
Cash / Share $0.93$4.65$3.48$2.14$3.18$15.04$11.08··$2.19$2.43$4.19
EPS (TTM) $-1.34$-2.17$-3.57$-5.86$-4.21·······
Valuasi (TTM) 10
Metrik Tren 202520242023202220212020201920182017201620152014
Revenue TTM ···········$3M
Net Income TTM $-57M$-45M$-40M$-66M$-47M$-34M$-8M$-21M$-30M$-29M$-21M$-3M
Market Cap $286M$185M$21M$30M$76M$271M$9M··$1.26B$10.24B$6.84B
P/E -4.0-2.4-0.5-0.5-1.6·······
P/S ···········2321.1
P/B 1.51.10.30.30.51.41.4··32.8161.583.0
P / Tangible Book 1.51.10.30.30.61.6······
P / Cash Flow -5.1-5.2-0.6-1.1-2.2-11.6-0.6··-53.3-582.8-684.9
P / FCF -5.1-5.2-0.6-1.1-2.2-11.2-0.6··-52.7-576.3-681.5
Earnings Yield -25.1%-41.1%-190.4%-218.7%-62.4%·······

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16
Metrik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Laba Bersih $-57M $-45M $-40M $-66M $-47M
EPS Dilusian $-1.34 $-2.17 $-3.57 $-5.86 $-4.21

Pemilik institusional (13F) 126 pengaju · $198.1M total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 126
Nilai yang dipegang $198.1M
Posisi baru 26
Posisi yang keluar 17
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
26 (-6 vs Kuartal sebelumnya) 17 (-4 vs Kuartal sebelumnya) 50 (+2 vs Kuartal sebelumnya) 29 (+5 vs Kuartal sebelumnya) -2.1M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
JANUS HENDERSON GROUP PLC $27.154.562 5.207.011 13,71% Saham
BlackRock, Inc. $13.994.565 3.663.499 7,06% Saham
VANGUARD GROUP INC $12.748.844 2.391.903 6,44% Saham
MILLENNIUM MANAGEMENT LLC $11.846.454 3.101.166 5,98% Saham
Velan Capital Investment Management LP $10.866.571 2.844.652 5,49% Saham
VANGUARD CAPITAL MANAGEMENT LLC $8.786.508 2.300.133 4,44% Saham
Blackstone Inc. $8.654.263 2.265.514 4,37% Saham
ORBIMED ADVISORS LLC $8.480.400 2.220.000 4,28% Saham
Sio Capital Management, LLC $7.341.551 1.921.872 3,71% Saham
ACORN CAPITAL ADVISORS, LLC $6.693.079 1.752.115 3,38% Saham
Integral Health Asset Management, LLC $5.730.000 1.500.000 2,89% Saham
5AM Venture Management, LLC $5.232.567 1.369.782 2,64% Saham
GEODE CAPITAL MANAGEMENT, LLC $5.067.467 1.326.246 2,56% Saham
CITADEL ADVISORS LLC $4.707.635 1.232.365 2,38% Saham
STATE STREET CORP $4.080.887 1.068.295 2,06% Saham
Qube Research & Technologies Ltd $3.993.871 1.045.516 2,02% Saham
Balyasny Asset Management L.P. $3.921.960 1.026.691 1,98% Saham
BAKER BROS. ADVISORS LP $3.711.565 971.614 1,87% Saham
ADAR1 Capital Management, LLC $3.592.756 940.512 1,81% Saham
BANK OF AMERICA CORP /DE/ $3.369.924 882.179 1,70% Saham
MARSHALL WACE, LLP $2.677.900 701.021 1,35% Saham
DIMENSIONAL FUND ADVISORS LP $2.611.855 683.230 1,32% Saham
NORTHERN TRUST CORP $2.109.809 552.306 1,06% Saham
Point72 Asset Management, L.P. $2.096.920 548.932 1,06% Saham
GOLDMAN SACHS GROUP INC $2.086.587 546.227 1,05% Saham
Catalio Capital Management, LP $1.986.965 520.148 1,00% Saham
MORGAN STANLEY $1.942.218 508.434 0,98% Saham
Walleye Capital LLC $1.930.750 505.432 0,97% Saham
VANGUARD PORTFOLIO MANAGEMENT LLC $1.878.130 491.657 0,95% Saham
UBS Group AG $1.744.873 456.773 0,88% Saham
VANGUARD FIDUCIARY TRUST CO $1.278.489 334.683 0,65% Saham
Verdad Advisers, LP $1.192.791 312.249 0,60% Saham
JACOBS LEVY EQUITY MANAGEMENT, INC $1.129.058 295.565 0,57% Saham
RENAISSANCE TECHNOLOGIES LLC $960.730 251.500 0,48% Saham
OPPENHEIMER & CO INC $910.543 238.362 0,46% Saham
AQR CAPITAL MANAGEMENT LLC $798.262 208.969 0,40% Saham
Jump Financial, LLC $775.842 203.100 0,39% Saham
CIBC WORLD MARKET INC. $636.011 166.495 0,32% Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $603.449 157.971 0,30% Saham
Bank of New York Mellon Corp $525.971 137.689 0,27% Saham
J. Goldman & Co LP $515.700 135.000 0,26% Saham
SUPERSTRING CAPITAL MANAGEMENT LP $463.966 121.457 0,23% Saham
Fisher Asset Management, LLC $380.342 99.566 0,19% Saham
AMERICAN CENTURY COMPANIES INC $376.220 98.487 0,19% Saham
BRIDGEWAY CAPITAL MANAGEMENT, LLC $325.961 85.330 0,16% Saham
Nuveen, LLC $277.371 72.610 0,14% Saham
TWO SIGMA INVESTMENTS, LP $266.071 69.652 0,13% Saham
FMR LLC $260.524 68.200 0,13% Saham
XTX Topco Ltd $244.281 63.948 0,12% Saham
RHUMBLINE ADVISERS $241.589 63.245 0,12% Saham

Tampilkan semua 126 pemilik institusional →

Aktivis & pemilik 5%+ 8 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn 8 Jan. 2021 · Pengajuan awal · SEC
Opaleye Management Inc., Opaleye, L.P., James Silverman ×3 pengajuan 25 Sep. 2020 · Pengajuan awal · SEC
Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×6 pengajuan 17 Jan. 2020 · Pengajuan awal · SEC
Abingworth LLP, Abingworth Bioventures VI, LP 17 Jan. 2020 · Pengajuan awal M&A / penjualan SEC
Abingworth LLP 98-051-8585, Abingworth Bioventures VI, LP 98-040-3543 ×3 pengajuan 14 Nov. 2019 · Pengajuan awal Kampanye dewan SEC
TVM Life Science Ventures VI L.P., TVM Life Science Ventures VI GmbH & Co. KG, TVM Life Science Ventures Management VI L.P., Hubert Birner, Stefan Fischer, Helmut Schuehsler ×2 pengajuan 2 Agu 2017 · Pengajuan awal Investasi pasif SEC
Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Mgmt III, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., James E. Flynn 29 Juni 2017 · Pengajuan awal Investasi pasif SEC
Skyline Venture Partners Qualified Purchaser Fund IV, L.P., Skyline Venture Management IV, LLC, John G. Freund, Yasunori Kaneko 3 Nov. 2014 · Pengajuan awal Investasi pasif SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 41 orang dalam · 16 pejabat · 20 direktur

19
Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Jesse Shefferman CEO and President 29 Juni 2026 M 691.832 0 1 $-882.160
Timothy P Noyes President and CEO 31 Jan. 2019 A 0 0 0 $0
Patrick Fabbio Chief Financial Officer 26 Jan. 2026 F 64.115 0 0 $0
Blaine Davis Chief Financial Officer 15 Juli 2022 F 20.662 0 0 $0
George Arthur Eldridge, Sr VP, CFO, Treasr, Asst Secy 18 Jan. 2019 A 29.132 0 0 $0
William Conkling Chief Commercial Officer 2 Juni 2026 F 69.992 0 0 $0
Jacqueline Zummo Chief R&D Officer 8 April 2026 S 94.827 0 2 $-124.989
Hannah Fry VP, Controller 26 Jan. 2026 F 42.723 0 0 $0
Leonardo Viana Nicacio Chief Medical Officer 16 Jan. 2026 A 78.181 0 0 $0
Jathin Bandari Chief Medical Officer 19 Jan. 2024 A 56.704 0 0 $0
Julio Casoy Chief Medical Officer 9 Jan. 2020 A 45.500 0 0 $0
Steven Keith Burke SVP and Chief Medical Officer 15 Maret 2019 G 26.332 0 0 $0
Bradley J Hartman VP, People 18 Jan. 2019 A · 0 0 $0
Matthew Paul Kowalsky VP, Legal and Secretary 18 Jan. 2019 A 29.479 0 0 $0
Scott E. Toner Senior VP of Commercial 18 Jan. 2019 A 23.357 0 0 $0
Gottlieb Daniel Philip VP Corporate Development 18 Jan. 2019 A 244 0 0 $0
Michael Edward Solomon Direktur 15 Juni 2026 A 26.500 0 0 $0
Jane Huang Direktur 15 Juni 2026 A · 0 0 $0
Barry P Flannelly Direktur 15 Juni 2026 A · 0 0 $0
Cynthia Smith Direktur 15 Juni 2026 A · 0 0 $0
Richard S Levy Direktur 15 Juni 2026 A 51.000 0 0 $0
Roger Garceau Direktur 15 Juni 2026 A 33.000 0 0 $0
Gregory Sargen Direktur 15 Juni 2026 A 31.000 0 0 $0
Luke M Beshar Direktur 15 Juni 2026 A 198.000 0 0 $0
Scott Braunstein Direktur 9 Juni 2020 A 26.500 0 0 $0
John Gordon Freund Direktur 8 Nov. 2019 C 2.175.882 0 0 $0
Hubert Birner Direktur 8 Juni 2018 A 1.943.059 0 0 $0
Paul J Hastings Direktur 8 Juni 2018 A · 0 0 $0
Scott A Canute Direktur 8 Juni 2018 A · 0 0 $0
Garen G Bohlin Direktur 8 Juni 2018 A 53.312 0 0 $0
Jonathan S Leff Direktur 8 Juni 2018 A · 0 0 $0
Brendan O'Leary Direktur 9 Juni 2016 A 1.387.198 0 0 $0
Dmitry Kobyzev Direktur 2 Juni 2015 A 1.165.344 0 0 $0
Gregory D Phelps Direktur 2 Juni 2015 A · 0 0 $0
Opaleye Management Inc. Pemilik 10% 12 Sep. 2024 S 45.000 0 0 $0
Opaleye, L.P. Pemilik 10% 9 Jan. 2020 A 2.208.472 0 0 $0
Martin Sebastian Olivo · 10 Juni 2021 P 14.344 0 0 $0
Randall Marshall · 14 Sep. 2020 S 585.600 0 0 $0
Timothy Haines · 12 Nov. 2019 C 2.144.517 0 0 $0
Abingworth LLP · 12 Nov. 2019 C 2.144.517 0 0 $0
Stuart A Kingsley · 8 Juni 2018 A · 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 17 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
IWC · iShares Trust 0,05% 179.945 SH 11 Sep. 2026 Harian
VFMO · VANGUARD WELLINGTON FUND 0,03% 141.979 SH 19 Agu 2026 Harian
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 300.912 SH 19 Agu 2026 Harian
VTWV · VANGUARD SCOTTSDALE FUNDS 0,01% 45.581 SH 19 Agu 2026 Harian
RSSL · Global X Funds 0,01% 24.988 NS 31 Juli 2026 N-PORT
IWM · iShares Trust 0,01% 1.339.324 SH 11 Sep. 2026 Harian
DFAS · Dimensional ETF Trust 0,00% 125.321 NS 31 Juli 2026 N-PORT
DXUV · Dimensional ETF Trust 0,00% 3.715 NS 31 Juli 2026 N-PORT
DFSU · Dimensional ETF Trust 0,00% 6.250 NS 31 Juli 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 5.791 NS 31 Juli 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 18.477 NS 31 Juli 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 20.174 NS 31 Juli 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 7.914 NS 31 Juli 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 586.965 SH 19 Agu 2026 Harian
VTI · VANGUARD INDEX FUNDS 0,00% 1.657.879 SH 19 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 3.185 SH 19 Agu 2026 Harian
IWN · iShares Trust · 472.468 SH 11 Sep. 2026 Harian

TARA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21
peringkat · 14 analis BELI
Target median $26.00 +863,0%
3 21,4% Beli Kuat
10 71,4% Beli
1 7,1% Tahan
0 0,0% Jual
0 0,0% Jual Kuat

Target Harga 12 Bulan

7 analis · 2026-10-01

Target rata-rata $25.71 +852,4%

← Di bawah semua target Harga saat ini $2.70
Rendah$20.00 Rata-rata$25.71 Tinggi$30.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
TARA $286M -4.0 · · -33.7% ·
DTIL $100M -1.2 -50.1% -133.4% -72.4% ·
ORGO $658M 34.5 17.0% 6.6% 13.9% ·
AVXL · -16.5 -36.1% -991.4% · ·
ALXO $61M -0.6 · · -225.0% ·
VYGR $232M -1.9 -49.5% -296.5% -54.4% ·
PEPG $448M -3.1 · · -82.0% ·
NERV $174M -0.1 · · 339.5% ·
NBP $1.06B -19.0 · · -21.4% ·
CMPX $958M · · · -45.9% ·
TNXP $200M -1.1 29.8% -946.2% -60.0% ·

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Sumber: SEC 10-Q diajukan Agu 11, 2026